Imunon (FRA:CBO0) E10: €-339.82 (As of Mar. 2026)


FRA:CBO0 Imunon Inc FRA:CBO0
26 GF Score
Price €1.30
! 2 Warning Signs
View Full Analysis

What is Imunon E10?

Imunon FRA:CBO0 -1.52% 26 E10 is €-339.82 as of Mar. 2026. GuruFocus rates FRA:CBO0 with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Imunon's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.727. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-339.82 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 32.20% per year. During the past 5 years, the average E10 Growth Rate was 32.90% per year. During the past 10 years, the average E10 Growth Rate was 22.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Imunon was 35.80% per year. The lowest was -15.60% per year. And the median was 18.80% per year.

As of today (2026-06-28), Imunon's current stock price is €1.30. Imunon's E10 for the quarter that ended in Mar. 2026 was €-339.82. Imunon's Shiller PE Ratio of today is .


Imunon  (FRA:CBO0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Imunon E10 Related Terms


Imunon E10 Historical Data

* Premium members only.

The historical data trend for Imunon's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imunon E10 Chart

Imunon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,352.44 -1,547.82 -1,132.62 -685.94 -387.01

Imunon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -719.18 -514.74 -496.28 -387.01 -339.82

FRA:CBO0 vs PMCB, CURX, LABT: E10 Comparison

For the Biotechnology subindustry, Imunon's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imunon Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Imunon's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Imunon's Shiller PE Ratio falls into.


FRA:CBO0
26GF Score
Imunon Inc FRA:CBO0
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imunon E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Imunon's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.727/330.2130*330.2130
=-0.727

Current CPI (Mar. 2026) = 330.2130.

Imunon Quarterly Data

per share eps CPI Adj_EPS
201606 -457.961 241.018 -627.441
201609 -561.327 241.428 -767.755
201612 -485.951 241.432 -664.648
201703 -565.266 243.801 -765.617
201706 -137.562 244.955 -185.441
201709 -114.906 246.819 -153.730
201712 -44.792 246.524 -59.998
201803 -39.668 249.554 -52.489
201806 -77.040 251.989 -100.955
201809 -43.595 252.439 -57.026
201812 55.033 251.233 72.334
201903 -20.778 254.202 -26.991
201906 -50.214 256.143 -64.735
201909 -44.413 256.759 -57.119
201912 -17.609 256.974 -22.628
202003 -35.413 258.115 -45.305
202006 -31.273 257.797 -40.058
202009 -39.866 260.280 -50.577
202012 -8.417 260.474 -10.671
202103 -36.266 264.877 -45.212
202106 -10.285 271.696 -12.500
202109 -10.422 274.310 -12.546
202112 -8.196 278.802 -9.707
202203 -21.555 287.504 -24.757
202206 -10.735 296.311 -11.963
202209 -11.461 296.808 -12.751
202212 -19.824 296.797 -22.056
202303 -8.284 301.836 -9.063
202306 -7.344 305.109 -7.948
202309 -4.522 307.789 -4.851
202312 -6.220 306.746 -6.696
202403 -6.240 312.332 -6.597
202406 -6.175 314.175 -6.490
202409 -3.388 315.301 -3.548
202412 -2.684 315.605 -2.808
202503 -2.914 319.799 -3.009
202506 -1.622 322.561 -1.660
202509 -0.988 324.800 -1.004
202512 -1.110 324.054 -1.131
202603 -0.727 330.213 -0.727

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-339.82 mean?
Imunon (FRA:CBO0) has a E10 of €-339.82 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Imunon and its competitors.
Is Imunon's E10 too high?
Imunon's current E10 is €-339.82. Overall, Imunon has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Imunon's E10 compare to PMCB and CURX?
Imunon's E10 of €-339.82 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Imunon and its competitors. Imunon's current E10 is €-339.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imunon stock overvalued right now?
Imunon (FRA:CBO0) has a current E10 of €-339.82. The current E10 is €-339.82. Imunon's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Imunon (FRA:CBO0), the current E10 is €-339.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imunon Business Description

Other Exchanges IMNN:USACBO0:Germany
Address 997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
26GF Score

Get the complete analysis for FRA:CBO0

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.30
Price